Multiple Sclerosis (MS) Clinical Trial
Official title:
Observational Study of the Physical Capacity of Patients With Multiple Sclerosis and Evaluation of the Effects of Usual Rehabilitation in the Day Hospital
The purpose of this study is to assess the physical capacity of patients with multiple sclerosis and the effects of rehabilitation, encompassing physical therapy and physical activity as it is carried out in the day hospital of (the Physical and Rehabilitation Medicine department) at Garches Hospital. We will compare the results of assessments carried out before and after a standard rehabilitation program.
Single center, retrospective and prospective study.
In order to assess the efficiency of the of usual rehabilitation proposed to patients in the
day hospital, assessments are systematically performed before and after the rehabilitation
program:
1. Assessment of muscular strength and fatigue:
Assessments of voluntary force will be those usually performed in the context of the
evaluation of patients. The isokinetic dynamometer CON-TREX ® is a device that provides
a quantified result of the torque developed in a predetermined joint area with a
constant speed which is also defined in advance.
The assessment includes an assessment of the strength in isometric contraction (at 40
and 90 degrees of knee flexion) and concentric contraction (30, 60 and 90 degrees per
second). Fatigue is evaluated by two self-administered questionnaires: the Fatigue
Severity Scale and Modified Fatigue Impact Scale.
2. Effort test:
The aerobic capacity of patients will be assessed by a triangular maximal exercise
test.
The effort test is performed on a cycle ergometer from a triangular incremental
exercise. Beforehand, blood pressure and ECG are recorded to establish that the patient
can safely achieve a gradual stress test. Heart rate, blood pressure, oxygen
consumption, the feeling (Borg scale) and ECG are recorded immediately before and
immediately after the end of the test and every minute for at least 5-10 minutes during
the recovery phase.
3. Clinical assessment:
The Timed Up and Go test will be used to assess the patient's capacity of postural
transition.
This is a timed quantitative assessment of the duration needed to change from sitting in a
chair, get up and walk three meters, make a U-turn and come back to sit down.
The 10 meters test quantifies the walking speed of patients (meters / second) over 10 meters
A test of ascending and descending10 stairs is also performed, as well as the 6 minutes
walking test.
In addition to these functional assessments, clinical tests are conventionally performed
such as the measurement of muscle strength (Medical Research Council scale), range of
motion, spasticity (modified Ashworth scale) and an assessment of the balance and posture.
The SEP-59 questionnaire will be used to assess the patients quality of life.
;
Observational Model: Cohort
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05177523 -
Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
|
||
Not yet recruiting |
NCT06053749 -
An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
|
||
Not yet recruiting |
NCT06450600 -
Enhancing Quality of Life in MS Patients Through Tailored Therapeutic Education
|
N/A | |
Recruiting |
NCT04926818 -
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
|
Phase 3 | |
Not yet recruiting |
NCT03624296 -
Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study
|
N/A | |
Terminated |
NCT04203498 -
Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
|
Phase 3 | |
Active, not recruiting |
NCT04602390 -
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
|
Phase 1 | |
Completed |
NCT01804647 -
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
|
||
Terminated |
NCT04907305 -
Next-Gen MS: Feed-forward PRO Data for MS Research
|
||
Active, not recruiting |
NCT03456206 -
Chronic Inflammatory Disease, Lifestyle and Risk of Disease
|
||
Completed |
NCT04705610 -
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography
|
N/A | |
Completed |
NCT01366027 -
PRISM Registry: Pseudobulbar Affect Registry Series
|
N/A | |
Completed |
NCT03135249 -
Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
|
Phase 4 | |
Recruiting |
NCT05633875 -
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
|
||
Completed |
NCT02612935 -
An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis
|
N/A | |
Completed |
NCT02739542 -
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
|
Phase 4 | |
Completed |
NCT03177655 -
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT04777539 -
Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
|
||
Completed |
NCT02308579 -
Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases
|
N/A | |
Completed |
NCT02019927 -
Electric Stimulation of the Eye to Improve Vision After Trauma
|
N/A |